article thumbnail

Apellis cites current challenges with Syfovre launch but bright prospects in the long term

Fierce Pharma

On Tuesday, when Apellis presented its quarterly earnings, its report raised more questions about Syfovre than it answered. . | The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a rollercoaster ride. And there are still more loops to negotiate.

article thumbnail

Episode 49 – Prospecting in the MedTech New Normal

Medical Device Success

Reading time: 2 – 2 minutes “What advice do you have related to prospecting for new customers in this new normal?” You can’t start the sales process unless you have a prospect! So, I decided to make the answer a slide presentation, podcast and videocast. This episode is purely about prospecting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 57 – MedScout – Helping Your Sales Team Prospect and Sell, A Revenue Intelligence Platform

Medical Device Success

Skylar Talley, CEO, MedScout joins us today to share how they go about pulling together and presenting procedural data, prescription data and firmographic information and then present it in a unique way to help medtech sales teams be more productive. Enter MedScout, a revenue intelligence platform for Life Science companies.

article thumbnail

The Sales Pro’s Guide to Sales Prospecting

Integrity Solutions

Sales prospecting is vital to the success of any sales organization. Why Is Sales Prospecting More Important Than Ever? They’ve also put new pressure on salespeople to hone their prospecting skills and redouble their efforts so they can turn effective sales prospecting into their success differentiator.

article thumbnail

Cognition's SHINE data for Alzheimer's drug dulls prospects

pharmaphorum

Cognition Therapeutics has reported phase 2 data with its Alzheimer's disease candidate, claiming the results show proof-of-concept for the drug, although the study missed its main endpoint.Cognition's stock lost more than 40% of its value in trading after the data was presented yesterday, and slipped another 20% after hours, despite assertions by (..)

article thumbnail

Oncolytic viruses: past and present

European Pharmaceutical Review

Prospects are hopeful as they are built upon decades of research establishing the incredible power of oncolytic viruses. The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.

article thumbnail

What should DTC do?

World of DTC Marketing

I’ve seen a lot of DTC presentations showing a correlation between reach and frequency and new Rxs, but most of that data is inaccurate. Unfortunately, too many are only interested in doing research with prospects, not customers. Is it because the DTC team and agency believe it will lead to more Rxs?

Doctors 243